Last reviewed · How we verify

NCT05324761

Management of Pain Associated With Failed Back Surgery Syndrome

Completed Phase 4 Last updated 1 May 2023
What this trial tests

Phase 4 trial testing Pregabalin 75mg in Failed Back Surgery Syndrome in 60 participants. Completed in 30 June 2022.

Timeline
25 April 2022
Primary endpoint
30 June 2022
30 June 2022

Quick facts

Lead sponsorAl-Kindy College of Medicine
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date25 April 2022
Primary completion30 June 2022
Estimated completion30 June 2022
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

Al-Kindy College of Medicine

Who can join

18 and older, any sex, with Failed Back Surgery Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Neuropathic pain is a common complication following different types of spine surgery making negative impact on health, along with life style changes and management, many neurologist prescribed either Pregabalin or Gabapentin to manage this condition with overall good results. our study aims to evaluate the efficacy of Pregabalin and Gabapentin in the management of this condition and to compare between them

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pregabalin versus Gabapentin Efficacy in the Management of Neuropathic Pain Associated with Failed Back Surgery Syndrome.
    Al-Ameri LT, Shukri ME, Hameed EK, Marzook AA. · · 2024 · cited 5× · PMID 37709550 · DOI 10.3340/jkns.2022.0225

Verify or expand the search:

Other trials of Pregabalin 75mg

Trials testing the same drug.

Other recruiting trials for Failed Back Surgery Syndrome

Currently open trials in the same condition.

Other Al-Kindy College of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05324761.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing